270 related articles for article (PubMed ID: 30473624)
1. Antiangiogenic Gene Therapy in Cancer.
Zhang L; Chen QR; Mixson AJ
Curr Genomics; 2000; 1(2):117-133. PubMed ID: 30473624
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor angiogenesis with gene therapy.
Chen QR; Zhang L; Gasper W; Mixson AJ
Mol Genet Metab; 2001; 74(1-2):120-7. PubMed ID: 11592809
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.
Ponnazhagan S; Mahendra G; Kumar S; Shaw DR; Stockard CR; Grizzle WE; Meleth S
Cancer Res; 2004 Mar; 64(5):1781-7. PubMed ID: 14996740
[TBL] [Abstract][Full Text] [Related]
4. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
8. Tumor Growth: A Putative Role for Platelets?
Verheul HM; Pinedo HM
Oncologist; 1998; 3(2):II. PubMed ID: 10388096
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
Hampl M; Tanaka T; Albert PS; Lee J; Ferrari N; Fine HA
Hum Gene Ther; 2001 Sep; 12(14):1713-29. PubMed ID: 11560766
[TBL] [Abstract][Full Text] [Related]
12. Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance.
Zarrin B; Zarifi F; Vaseghi G; Javanmard SH
J Res Med Sci; 2017; 22():117. PubMed ID: 29184575
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of angiostatin K1-3 and endostatin genes coadministered by the hydrodynamics-based transfection method.
Kim KS; Park YS
Oncol Res; 2005; 15(7-8):343-50. PubMed ID: 16491952
[TBL] [Abstract][Full Text] [Related]
15. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy.
Nguyen JT; Wu P; Clouse ME; Hlatky L; Terwilliger EF
Cancer Res; 1998 Dec; 58(24):5673-7. PubMed ID: 9865720
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of Antiangiogenic Therapy Into the Non-Small-Cell Lung Cancer Paradigm.
Chu BF; Otterson GA
Clin Lung Cancer; 2016 Nov; 17(6):493-506. PubMed ID: 27381269
[TBL] [Abstract][Full Text] [Related]
20. Role of angiogenesis in tumor growth and metastasis.
Folkman J
Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
